Pharma Focus Asia

Aenova Invests US$10.5 million (10 million Euros) to Enhance its Production Capacity in Italy

Introduction:
Aenova invests around US$10.5 million (10 million Euros) in additional production capacity for semi-solids and non-sterile liquids at their Carugate site, Italy.

Features:
The new plant will be installed with more modern and efficient equipment. 

With this investment, the new plant will enable the implementation of a new filling line for non-sterile liquids, a more efficient turbo-emulsifier, and a larger warehouse. 

New Filling Line for Non-Sterile Liquids: This new filling line will increase capacity to over 10 million units per year. It is versatile, capable of filling bottles with various dosages (ranging from 10 ml to 350 ml) and different closure types (screw or crimp of metal and plastic cap, spray, dropper).

Turbo-Emulsifier: The installation of a more efficient turbo-emulsifier will enable the manufacturing of batch sizes ranging from 300 litres to 5,000 litres. This will also allow the production of different products, including flammable liquids, as the area is ATEX rated.

Larger Warehouse: A newly constructed warehouse next to the plant will provide nearly 3,000 additional pallet spaces, ensuring sufficient in-house GMP storage to meet the growing demand.

The new plant is expected to be fully equipped with modern and efficient equipment by the end of 2023.

Specifications:
Name     Aenova
Type      Expansion
Budget   US$10.5 million (10 million Euros)
Year       2023

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference